The Global Organ Preservation Solution Market Size is projected to grow at a CAGR of 9.7% during the forecast period from 2026 to 2034 | DelveInsight

The Organ Preservation Solution market is estimated at USD 340 million in 2025 and is projected to reach USD 785 million by 2034. Growth is anchored by the rising number of organ transplant procedures, the growing burden of end-stage organ failure, increasing organ donation rates, expansion of transplant centers and organ procurement organizations, and increasing government initiatives supporting organ donation.

DelveInsight's Organ Preservation Solution Market Insights Report 2034 provides the current and forecast market analysis, individual leading Organ Preservation Solution companies' market shares, challenges, Organ Preservation Solution Market Drivers, barriers, trends, and key market Organ Preservation Solution companies in the market.

To read more about the latest highlights related to the Organ Preservation Solution Market @
https://www.delveinsight.com/report-store/organ-preservation-solution-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Organ Preservation Solution Market Report

• In May 2026, Bridge to Life Ltd. presented data at the ILTS 2026 meeting showing that its VitaSmart hypothermic oxygenated perfusion system expands usable livers from steatotic and older donors while preserving mitochondrial function for real-time viability assessment. Strategic significance: Reinforces Bridge to Life's leadership in perfusion-based preservation and strengthens the clinical case for wider hypothermic oxygenated perfusion adoption.
• In March 2026, Duke University Hospital became the first US transplant center to commercially implement Bridge to Life's VitaSmart hypothermic oxygenated perfusion system, using it to preserve a donation-after-circulatory-death donor liver before transplantation. Strategic significance: Demonstrates early physician confidence and commercial traction for Bridge to Life's FDA-cleared perfusion platform.
• In October 2025, Bridge to Life received FDA 510(k) clearance for multi-sourced Belzer UW and MPS solutions, with expanded labeling that lets Belzer MPS support hypothermic machine perfusion across all abdominal organs, a first for the field. Strategic significance: Broadens the approved use of an established preservation solution and expands machine-perfusion options for abdominal organ transplants.
• The global Organ Preservation Solution market is growing at a CAGR of 9.7% during the forecast period from 2026 to 2034.
• The principal drivers are rising organ transplant volumes worldwide; a growing and diversifying donor pool that increasingly includes marginal and extended-criteria organs; rising prevalence of end-stage organ failure and related chronic disease; continued advances in hypothermic and normothermic machine perfusion; growing government and institutional investment in organ donation infrastructure; and ongoing development of next-generation preservation chemistries.
• The leading Organ Preservation Solution Companies include Bridge to Life Ltd., XVIVO Perfusion AB, Institut Georges Lopez (IGL), Dr. Franz Köhler Chemie GmbH, Organ Recovery Systems, TransMedics, Inc., OrganOx Limited, Preservation Solutions, Inc., Essential Pharmaceuticals LLC, and Paragonix Technologies, among others.

To know more about why North America is leading the market growth in the Organ Preservation Solution Market, Get a snapshot @
https://www.delveinsight.com/report-store/organ-preservation-solution-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Organ Preservation Solution Overview

An organ preservation solution is a specialized sterile biochemical fluid designed to maintain the structural integrity, viability, and physiological function of donor organs from the time they are recovered until transplantation. These solutions reduce ischemic injury by slowing cellular metabolism, preventing tissue swelling, maintaining electrolyte balance, buffering pH changes, scavenging free radicals, and protecting cell membranes during cold storage or machine perfusion. They contain a carefully balanced mix of electrolytes, impermeants, osmotic agents, antioxidants, energy substrates, and buffering compounds that preserve cellular homeostasis while reducing oxidative stress. Widely used solutions include University of Wisconsin (UW) Solution , Celsior Solution, Institut Georges Lopez (IGL) Solution, and Perfadex for lung preservation, with the choice of solution depending on organ type, preservation technique, and expected ischemic duration.

Organ Preservation Solution Market Key Growth Drivers

• Rising organ transplant volumes worldwide are the single biggest driver, with the United States performing 48,149 total organ transplants in 2024, nearly 132 procedures per day, and global transplant activity reported to the WHO-ONT Global Observatory exceeding 172,000 procedures in 2023, up 9.5% over 2022.
• An expanding and diversifying donor pool is broadening demand for advanced preservation chemistry, as donation-after-circulatory-death donors made up 36% of US deceased donors in 2023, requiring preservation approaches suited to organs that have already experienced a period of warm ischemia.
• Growing use of extended-criteria and marginal organs, including older and steatotic donor livers, is increasing reliance on hypothermic oxygenated perfusion, which has shown improved graft outcomes and preserved mitochondrial function in these higher-risk organs.
• Rising prevalence of end-stage organ failure and related chronic disease, including chronic kidney disease, liver cirrhosis, and heart failure, is expanding the global transplant candidate pool and, with it, demand for effective preservation technologies.
• Continuous advances in hypothermic machine perfusion, normothermic machine perfusion, and ex vivo organ perfusion systems are driving adoption of specialized preservation solutions optimized for dynamic perfusion.
• Growing government, transplant-organization, and healthcare-institution investment in organ donation awareness and transplant infrastructure is increasing the number of donor organs recovered and preserved.
• Regulatory approvals and continued development of next-generation preservation solutions with enhanced antioxidant, anti-inflammatory, and cytoprotective properties are improving graft survival and expanding adoption across organ types.

Get a sneak peek at the Organ Preservation Solution Market Dynamics @
https://www.delveinsight.com/report-store/organ-preservation-solution-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Organ Preservation Solution Market Segment Analysis

The Organ Preservation Solution Market by Product Type (Organ Preservation Solutions [UW Solution, HTK Solution, Celsior Solution, IGL-1 Solution, Perfadex, EuroCollins/Collins Solution, and Others] and Perfusion Solutions/Machine Perfusion [Hypothermic Machine Perfusion Solutions, Hypothermic Oxygenated Perfusion Solutions, Normothermic Machine Perfusion Solutions, Subnormothermic/Controlled Oxygenated Rewarming Solutions, and Other Proprietary Perfusion Solutions]), Application (Procurement, Preservation, Transportation, Pre-Implantation, and Post-Implantation), Organ Type (Kidney, Liver, Heart, Pancreas, and Others), and Geography (North America, Europe, Asia-Pacific, Rest of World).

• By product/solution type, organ preservation solutions led the market with 61% share in 2025, with UW solution the leading formulation given its decades-long track record across kidney, liver, and pancreas preservation, while HTK is favored for cardiac use and Perfadex remains the standard flush solution in most lung transplant clinics worldwide.
• By application, the preservation segment led with 38% share in 2025, as it represents the core, unavoidable use case for every donor organ between recovery and implantation.
• By organ type, kidney led with 42% share in 2025, consistent with kidney transplants making up the largest share of transplant volume globally.
• North America led global revenue with 41% share in 2025, the largest of any region, while Asia-Pacific is the fastest-growing region, driven by rising organ failure prevalence and rapid transplant infrastructure expansion.

Which MedTech key players in the Organ Preservation Solution Market are set to emerge as the trendsetter explore @
https://www.delveinsight.com/report-store/organ-preservation-solution-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Organ Preservation Solution Market Competitive Landscape

The Organ Preservation Solution market is classified as Fragmented. A semi-consolidated group of established manufacturers, including Bridge to Life, XVIVO Perfusion, Dr. Franz Köhler Chemie, and Institut Georges Lopez, anchors the leading tier through proprietary formulations, regulatory approvals, and global distribution networks, while numerous smaller regional producers compete through localized distribution, pricing, and niche organ-specific formulations, sustaining a broad and competitive supplier base.

Organ Preservation Solution Companies

• Bridge to Life Ltd.
• XVIVO Perfusion AB
• Institut Georges Lopez (IGL)
• Dr. Franz Köhler Chemie GmbH
• Organ Recovery Systems
• TransMedics, Inc.
• OrganOx Limited
• Preservation Solutions, Inc.
• Essential Pharmaceuticals LLC
• Paragonix Technologies
• and others.

Organ Preservation Solution Market Restraints

• Despite strong momentum, the Organ Preservation Solution market faces material constraints.
• Machine perfusion solutions and the platforms that deliver them cost substantially more than conventional static cold storage, which can limit adoption among smaller transplant centers and in cost-constrained healthcare systems.
• The short viable window of donor organs imposes severe time and logistics constraints, requiring precise cold-chain handling and rapid transportation that can be difficult to guarantee across long distances or in regions with underdeveloped transplant infrastructure.
• Regulatory approval pathways for new preservation and perfusion chemistries can be lengthy, slowing the pace of new product introduction, and reimbursement for machine perfusion remains uneven across geographies.
• A shortage of personnel trained in perfusion techniques constrains scale-up at transplant centers seeking to adopt newer technologies, and global supply chain fragility, including periodic delivery constraints for certain branded preservation solutions, can disrupt availability.
• The persistent gap between organ demand and donor supply also continues to cap addressable procedure volume in many countries.

Interested in knowing the Organ Preservation Solution Market by 2034? Click to get a snapshot of the Organ Preservation Solution Market Trends:
https://www.delveinsight.com/report-store/organ-preservation-solution-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Organ Preservation Solution Market Report

• Coverage- Global
• Forecast Period- 2026-2034
• Organ Preservation Solution Companies- Bridge to Life Ltd., XVIVO Perfusion AB, Institut Georges Lopez (IGL), Dr. Franz Köhler Chemie GmbH, Organ Recovery Systems, TransMedics, Inc., OrganOx Limited, Preservation Solutions, Inc., Essential Pharmaceuticals LLC, Paragonix Technologies, and others.
• Organ Preservation Solution Market Restraints and Regulatory Analysis
• Organ Preservation Solution Porter Five Forces Analysis and Market Assessment

Explore more information of the Organ Preservation Solution Market Insights @
https://www.delveinsight.com/report-store/organ-preservation-solution-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

• Organ Preservation Solution Market Report Introduction
• Organ Preservation Solution Market Executive Summary
• Organ Preservation Solution Market Key Factors Analysis
• Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
• Regulatory Analysis
• Organ Preservation Solution Market Porter's Five Forces Analysis
• Organ Preservation Solution Market Assessment
• Organ Preservation Solution Market Competitive Landscape
• Organ Preservation Solution Market Startup Funding and Investment Trends
• Organ Preservation Solution Market Company and Product Profiles
• KOL Views
• Project Approach
• About DelveInsight
• Disclaimer and Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.